Company Overview and News
2018-07-25 247wallst - 4
Stocks were set to open lower on Wednesday morning after a strong Tuesday. Earnings season is in full swing. The investing community has dealt with more volatility in 2018 and frankly has had less success with lower rewards from buying the dips in 2018 than in prior years. Many of those same investors also are reconsidering how they want their investments positioned ahead of the midterm elections and given international trade concerns.
LMT PM RIO DB RIO HA SAM GOL RTPPF SPOT AVGO RTNTF AGR MS CROX KDP TRU SAVE LLY HRL LFC 2628 PPG RIO TRI LFC BRCM LM
Good day, ladies and gentlemen and welcome to the Second Quarter 2018 Avangrid, Inc. earnings conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]
Duke Energy’s (DUK - Free Report) subsidiary — Duke Energy Carolinas — applied for new rates to the North Carolina Utilities Commission (“NCUC”). The company will pass the savings from recent federal tax reform to all customers groups. The new electric rates will be phased out over the next four years and will decline by average 1.34% post NCUC’s approval and adjust to a 0.22% fall in August 2022 However, residential customers will experience a marginal increase in utility bills.
WFCNP SOJA AGR NEE WFC SO DUKH UNP DUK
Duke Energy Corporation (DUK - Free Report) announced that its subsidiary — Duke Energy Renewables — has finalized the acquisition of the Shoreham Solar Commons project from Invenergy. Located in Brookhaven, NY, the facility is one of the largest solar projects in New York and has a capacity to generate 24.9 megawatts (MW) of solar power.
NRGEO NRG DUKH AEE AGR DUK
Atlantica Yield’s (AY - Free Report) earnings estimates have been revised upward over the past 60 days, reflecting analysts’ confidence in the stock. The Zacks Consensus Estimate for 2018 and 2019 earnings has moved 26.1% and 22.4% north to 87 cents and $1.04 per share, respectively, within the same time frame. Atlantica Yield, a Zacks Rank #1 (Strong Buy) stock, owns, acquires and operates renewable energy, natural gas, power, electric transmission lines, and water assets in North America, South America, Spain, Algeria, and South Africa.
NI AY AGR AQN
Earnings estimates for Atmos Energy Corporation (ATO - Free Report) have been revised upward over the past 60 days, reflecting analysts’ confidence in the stock. The Zacks Consensus Estimate for 2018 earnings has moved 0.5% north to $3.99 per share. Atmos Energy, along with subsidiaries, is engaged in regulated natural gas distribution and storage business. The company serves in excess of three million natural gas distribution customers across more than 1,400 communities in eight states from the Blue Ridge Mountains in the East to the Rocky Mountains in the West.
NI AEE AGR ATO
Duke Energy Corporation (DUK - Free Report) recently announced that the board of directors approved a quarterly cash dividend of 93 cents per share on its common stock. This would mark a quarterly increase of 3.75 cents or 4.2%. Per the company, the dividend will be payable on Sep 17, 2018 to stockholders on record as of Aug 17. The estimated annual yield on the dividend is 4.3%. Regular Distribution Hikes Duke Energy has been raising its cash dividend per share every year and this is the 92nd consecutive year, in which the company has continued with the same trend.
NRGEO NRG DUKH AEE AGR CVRR DUK
Earnings estimates for CMS Energy Corporation (CMS - Free Report) have been revised upward in the past 30 days. The Zacks Consensus Estimate for 2019 has inched up 0.4% to $2.51. Estimates for 2018 remain unchanged at $2.33. CMS Energy’s earnings have surpassed the Zacks Consensus Estimate in three out of the trailing four quarters. In a year's time, the stock has returned 4.9% against its industry’s decline of 0.
AEE CMSA OTTR AGR CMS
Duke Energy (NYSE:DUK) will pass on an amount of $142 million in annual tax savings to the electric bills of its Indiana-based customers, if the proposed settlement with consumer groups is approved by Indiana Utility Regulatory Commission.
DUKH WGL AGR DUK NEE
Duke Energy Corp. (DUK - Free Report) will pass on an amount of $142 million in annual tax savings to the electric bills of its Indiana-based customers, if the proposed settlement with consumer groups is approved by Indiana Utility Regulatory Commission. The Tax Cuts and Jobs Act — amended in late 2017 — came into effect on Jan 1, 2018 and has clearly led to this entire bill reduction. Details of Tax Savings The company’s customers, particularly residing in Indiana, would save approximately $142 million in annual tax on their electric bills.
DUKH WGL AGR DUK NEE
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to AGR / Avangrid, Inc. on message board site Silicon Investor.
as of ET